How to buy National Health Investors shares

Easy steps to invest in National Health Investors stock in the UK.

National Health Investors Inc (NHI) is a publicly traded reit - healthcare facilities business based in the US which employs around 30 staff. National Health Investors is listed on the NYSE and traded in US dollars. Its current price of $72.51 is 3.8% down on its price a month ago ($75.37).

How to buy shares in National Health Investors

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. To trade US shares you'll need to complete a W8-BEN form – typically part of the sign-up process.
  2. Fund your account. Add money to your account via bank transfer or debit card.
  3. Search the platform by ticker symbol. NHI in this case.
  4. Choose an order type. Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy National Health Investors shares

Best for 0% commission stocks
eToro logo
Finder Award
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Best for uninvested cash
IG logo
Capital at risk. T&Cs apply.
Up to 4.25% interest on uninvested cash
11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools
Best for fractional shares
XTB logo
Capital at risk. T&Cs apply.
Earn 4.5% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs

National Health Investors stock chart

Use our graph to track the performance of NHI stock over time.

Fees calculator for buying National Health Investors shares with popular apps

Find the cheapest way to buy National Health Investors shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).

Quantity of shares

12
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro logo
9 Excellent
£0 $100 £656.43
Go to siteCapital at risk
Freetrade logo
9.1 Excellent
£0 £0 £658.00
Go to siteCapital at risk
IG logo
9 Excellent
From £0 £0 £656.11
Go to siteCapital at risk
Robinhood logo
8.8 Great
£0 £0 £651.74
Go to siteCapital at risk
XTB logo
9.2 Excellent
£0 £0 £654.80
Go to siteCapital at risk
Hargreaves Lansdown logo
8.5 Great
£0 (0.45% for funds) £1 £670.01
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is it a good time to buy National Health Investors stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View National Health Investors's price performance, share price volatility, historical data and technicals.

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Historical closes compared with the last close of $72.51

1 week (2025-05-23) 0.06%
1 month (2025-04-30) -3.79%
3 months (2025-03-02) 1.17%
6 months (2024-11-30) -5.03%
1 year (2024-05-30) 9.73%
2 years (2023-05-30) 38.30%
3 years (2022-05-30) 22.01%
5 years (2020-05-30) 27.88%
Promoted
eToro
Invest in National Health Investors shares
Finder AwardFree Trades
  • Over 5,500+ stocks from 20 exchanges
  • Free to open an account
  • Commission-free trading

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is National Health Investors under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the National Health Investors P/E ratio, PEG ratio and EBITDA.

National Health Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, National Health Investors's shares trade at around 23x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

National Health Investors's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.99. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into National Health Investors's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

National Health Investors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $264.9 million (£196.5 million).

The EBITDA is a measure of National Health Investors's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

More guides on Finder

Go to site